| Name | tert-butyl 3-benzyl-4-oxopiperidine-1-carboxylate |
|---|---|
| Synonyms | 3-benzyl-4-oxopiperidine-1-carboxylic acid tert-butyl ester |
| Density | 1.115g/cm3 |
|---|---|
| Boiling Point | 409ºC at 760mmHg |
| Molecular Formula | C17H23NO3 |
| Molecular Weight | 289.36900 |
| Flash Point | 201.2ºC |
| Exact Mass | 289.16800 |
| PSA | 46.61000 |
| LogP | 2.99310 |
| Vapour Pressure | 6.69E-07mmHg at 25°C |
| Index of Refraction | 1.534 |
| Storage condition | 2-8°C |
| Hazard Codes | Xi |
|---|---|
| HS Code | 2933399090 |
|
~87%
193274-82-7 |
| Literature: Takeda Pharmaceutical Company Limited Patent: EP1553084 A1, 2005 ; Location in patent: Page/Page column 54 ; |
|
~%
193274-82-7 |
| Literature: Bioorganic and Medicinal Chemistry Letters, , vol. 17, # 20 p. 5704 - 5708 |
| Precursor 2 | |
|---|---|
| DownStream 0 | |
| HS Code | 2933399090 |
|---|---|
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |